SD Biosensor, Inc. (KRX:137310)
South Korea · Delayed Price · Currency is KRW
8,320.00
-120.00 (-1.42%)
Mar 3, 2026, 1:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Diagnostic Kits / Equipment | 694.57B | 655.68B | 2.93T | 2.93T | - | |
Diagnostic Kits / Equipment Growth | 5.93% | -77.64% | 0.07% | - | - | |
| - | - | - | - | 9.80B | |
| - | - | - | - | 361.59% | |
| - | - | - | - | 1.63T | |
POCT Blood Sugar Division | - | - | - | - | 45.51B | |
POCT Blood Sugar Division Growth | - | - | - | - | -5.24% | |
| 694.57B | 655.68B | 2.93T | 2.93T | 1.69T | |
| 5.93% | -77.64% | 0.07% | 73.76% | 2211.01% | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 48.16B | 73.97B | 431.06B | 194.31B | 41.41B | |
| -34.89% | -82.84% | 121.84% | 369.26% | 165.76% | |
| 96.87B | 89.72B | 358.56B | 687.44B | 679.25B | |
| 7.97% | -74.98% | -47.84% | 1.21% | 4120.66% | |
| 174.10B | 195.60B | 1.70T | 1.68T | 708.64B | |
| -10.99% | -88.49% | 0.95% | 137.45% | 3904.65% | |
| 320.16B | 252.82B | 385.09B | 172.90B | 164.89B | |
| 26.64% | -34.35% | 122.72% | 4.86% | - | |
| 34.50B | 31.83B | 44.99B | 105.09B | - | |
| 8.39% | -29.25% | -57.19% | - | - | |
| 20.78B | 11.74B | 13.53B | 85.83B | 78.89B | |
| 77.05% | -13.26% | -84.23% | 8.79% | 2220.22% | |
| - | - | - | 1.68B | 13.09B | |
| - | - | - | -87.15% | - | |
| 694.57B | 655.68B | 2.93T | 2.93T | 1.69T | |
| 5.93% | -77.64% | 0.07% | 73.76% | 2211.01% | |
Source: S&P Global Market Intelligence.